187 related articles for article (PubMed ID: 27698228)
21. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
Buzková H; Pechandová K; Slanar O; Perlík F
Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
[TBL] [Abstract][Full Text] [Related]
22. Rifampin-Mediated Induction of Tamoxifen Metabolism in a Humanized PXR-CAR-CYP3A4/3A7-CYP2D6 Mouse Model.
Chang JH; Chen J; Liu L; Messick K; Ly J
Drug Metab Dispos; 2016 Nov; 44(11):1736-1741. PubMed ID: 27538915
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 Regulates the Expression of
Siswanto FM; Handayani MDN; Firmasyah RD; Oguro A; Imaoka S
Curr Drug Metab; 2023; 24(9):667-681. PubMed ID: 37916628
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of drug transporter regulation.
Tirona RG
Handb Exp Pharmacol; 2011; (201):373-402. PubMed ID: 21103976
[TBL] [Abstract][Full Text] [Related]
25. Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.
Shen HW; Wu C; Jiang XL; Yu AM
Biochem Pharmacol; 2010 Jul; 80(1):122-8. PubMed ID: 20206139
[TBL] [Abstract][Full Text] [Related]
26. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
LLerena A; Naranjo ME; Rodrigues-Soares F; Penas-LLedó EM; Fariñas H; Tarazona-Santos E
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1569-83. PubMed ID: 25316321
[TBL] [Abstract][Full Text] [Related]
27. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism.
Eloranta JJ; Kullak-Ublick GA
Arch Biochem Biophys; 2005 Jan; 433(2):397-412. PubMed ID: 15581596
[TBL] [Abstract][Full Text] [Related]
28. The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity.
Ourlin JC; Lasserre F; Pineau T; Fabre JM; Sa-Cunha A; Maurel P; Vilarem MJ; Pascussi JM
Mol Endocrinol; 2003 Sep; 17(9):1693-703. PubMed ID: 12805410
[TBL] [Abstract][Full Text] [Related]
29. Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1.
Meyer Zu Schwabedissen HE; Böttcher K; Chaudhry A; Kroemer HK; Schuetz EG; Kim RB
Hepatology; 2010 Nov; 52(5):1797-807. PubMed ID: 20827719
[TBL] [Abstract][Full Text] [Related]
30. Changes in the defined daily dose; CYP2D6/CYP3A metabolism as an indicator for dose-setting problems.
Stolk P; Heerdink ER; Leufkens HG
Eur J Clin Pharmacol; 2005 May; 61(3):243-6. PubMed ID: 15864570
[TBL] [Abstract][Full Text] [Related]
31. Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus?
Kragelund C; Hansen C; Reibel J; Nauntofte B; Broesen K; Pedersen AM; Smidt D; Eiberg H; Torpet LA
J Oral Pathol Med; 2009 Jan; 38(1):63-71. PubMed ID: 19192051
[TBL] [Abstract][Full Text] [Related]
32. Nuclear receptors and drug disposition gene regulation.
Tirona RG; Kim RB
J Pharm Sci; 2005 Jun; 94(6):1169-86. PubMed ID: 15858847
[TBL] [Abstract][Full Text] [Related]
33. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
Shen H; He MM; Liu H; Wrighton SA; Wang L; Guo B; Li C
Drug Metab Dispos; 2007 Aug; 35(8):1292-300. PubMed ID: 17470523
[TBL] [Abstract][Full Text] [Related]
34. Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of quetiapine and N-desalkylquetiapine in psychiatric patients.
Bakken GV; Molden E; Hermann M
Ther Drug Monit; 2015 Apr; 37(2):256-61. PubMed ID: 25254417
[TBL] [Abstract][Full Text] [Related]
35. Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokinetics.
Swaisland HC; Cantarini MV; Fuhr R; Holt A
Clin Pharmacokinet; 2006; 45(6):633-44. PubMed ID: 16719544
[TBL] [Abstract][Full Text] [Related]
36. Developmental changes in human liver CYP2D6 expression.
Stevens JC; Marsh SA; Zaya MJ; Regina KJ; Divakaran K; Le M; Hines RN
Drug Metab Dispos; 2008 Aug; 36(8):1587-93. PubMed ID: 18474679
[TBL] [Abstract][Full Text] [Related]
37. Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression.
Temesvári M; Kóbori L; Paulik J; Sárváry E; Belic A; Monostory K
J Pharmacol Exp Ther; 2012 Apr; 341(1):294-305. PubMed ID: 22262920
[TBL] [Abstract][Full Text] [Related]
38. Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.
Morgan ET; Dempsey JL; Mimche SM; Lamb TJ; Kulkarni S; Cui JY; Jeong H; Slitt AL
Drug Metab Dispos; 2018 May; 46(5):503-513. PubMed ID: 29514828
[TBL] [Abstract][Full Text] [Related]
39. The role of drug interactions in interindividual variability of drug metabolism in man.
Sjöqvist F
Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S35-6. PubMed ID: 558530
[No Abstract] [Full Text] [Related]
40. Nuclear receptors in drug metabolism and beyond.
Xie W; Chiang JY
Drug Metab Rev; 2013 Feb; 45(1):1-2. PubMed ID: 23330537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
